193 related articles for article (PubMed ID: 8975778)
1. Differential binding of HMG1, HMG2, and a single HMG box to cisplatin-damaged DNA.
Farid RS; Bianchi ME; Falciola L; Engelsberg BN; Billings PC
Toxicol Appl Pharmacol; 1996 Dec; 141(2):532-9. PubMed ID: 8975778
[TBL] [Abstract][Full Text] [Related]
2. The effect of the acidic tail on the DNA-binding properties of the HMG1,2 class of proteins: insights from tail switching and tail removal.
Lee KB; Thomas JO
J Mol Biol; 2000 Nov; 304(2):135-49. PubMed ID: 11080451
[TBL] [Abstract][Full Text] [Related]
3. Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.
Ohndorf UM; Rould MA; He Q; Pabo CO; Lippard SJ
Nature; 1999 Jun; 399(6737):708-12. PubMed ID: 10385126
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.
Nagatani G; Nomoto M; Takano H; Ise T; Kato K; Imamura T; Izumi H; Makishima K; Kohno K
Cancer Res; 2001 Feb; 61(4):1592-7. PubMed ID: 11245470
[TBL] [Abstract][Full Text] [Related]
5. Structure-specific binding of the two tandem HMG boxes of HMG1 to four-way junction DNA is mediated by the A domain.
Webb M; Thomas JO
J Mol Biol; 1999 Nov; 294(2):373-87. PubMed ID: 10610765
[TBL] [Abstract][Full Text] [Related]
6. Localization of the binding region of high mobility group protein 2 to cisplatin-damaged DNA.
Lawrence DL; Engelsberg BN; Farid RS; Hughes EN; Billings PC
J Biol Chem; 1993 Nov; 268(32):23940-5. PubMed ID: 8226934
[TBL] [Abstract][Full Text] [Related]
7. A novel family of plant DNA-binding proteins containing both HMG-box and AT-rich interaction domains.
Hansen FT; Madsen CK; Nordland AM; Grasser M; Merkle T; Grasser KD
Biochemistry; 2008 Dec; 47(50):13207-14. PubMed ID: 19053246
[TBL] [Abstract][Full Text] [Related]
8. Characterization of high mobility group protein binding to cisplatin-damaged DNA.
Billings PC; Davis RJ; Engelsberg BN; Skov KA; Hughes EN
Biochem Biophys Res Commun; 1992 Nov; 188(3):1286-94. PubMed ID: 1445361
[TBL] [Abstract][Full Text] [Related]
9. DNA sequence context and protein composition modulate HMG-domain protein recognition of cisplatin-modified DNA.
Dunham SU; Lippard SJ
Biochemistry; 1997 Sep; 36(38):11428-36. PubMed ID: 9298962
[TBL] [Abstract][Full Text] [Related]
10. Differences in DNA recognition and conformational change activity between boxes A and B in HMG2 protein.
Yoshioka Ki; Saito K; Tanabe T; Yamamoto A; Ando Y; Nakamura Y; Shirakawa H; Yoshida M
Biochemistry; 1999 Jan; 38(2):589-95. PubMed ID: 9888798
[TBL] [Abstract][Full Text] [Related]
11. Structural requirements for cooperative binding of HMG1 to DNA minicircles.
Webb M; Payet D; Lee KB; Travers AA; Thomas JO
J Mol Biol; 2001 May; 309(1):79-88. PubMed ID: 11491303
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen.
Ise T; Nagatani G; Imamura T; Kato K; Takano H; Nomoto M; Izumi H; Ohmori H; Okamoto T; Ohga T; Uchiumi T; Kuwano M; Kohno K
Cancer Res; 1999 Jan; 59(2):342-6. PubMed ID: 9927044
[TBL] [Abstract][Full Text] [Related]
13. Intracellular distribution of HMG1, HMG2 and UBF change following treatment with cisplatin.
Chao JC; Wan XS; Engelsberg BN; Rothblum LI; Billings PC
Biochim Biophys Acta; 1996 Jun; 1307(2):213-9. PubMed ID: 8679707
[TBL] [Abstract][Full Text] [Related]
14. Human testis-determining factor SRY binds to the major DNA adduct of cisplatin and a putative target sequence with comparable affinities.
Trimmer EE; Zamble DB; Lippard SJ; Essigmann JM
Biochemistry; 1998 Jan; 37(1):352-62. PubMed ID: 9425057
[TBL] [Abstract][Full Text] [Related]
15. Photoreactivity of platinum(II) in cisplatin-modified DNA affords specific cross-links to HMG domain proteins.
Kane SA; Lippard SJ
Biochemistry; 1996 Feb; 35(7):2180-8. PubMed ID: 8652559
[TBL] [Abstract][Full Text] [Related]
16. HMG box proteins bind to four-way DNA junctions in their open conformation.
P-ohler JR; Norman DG; Bramham J; Bianchi ME; Lilley DM
EMBO J; 1998 Feb; 17(3):817-26. PubMed ID: 9451006
[TBL] [Abstract][Full Text] [Related]
17. Solution structure and DNA binding property of the fifth HMG box domain in comparison with the first HMG box domain in human upstream binding factor.
Yang W; Xu Y; Wu J; Zeng W; Shi Y
Biochemistry; 2003 Feb; 42(7):1930-8. PubMed ID: 12590579
[TBL] [Abstract][Full Text] [Related]
18. Unwinding of DNA by nonhistone protein HMG1 and HMG2.
Yoshida M; Makiguchi K; Chida Y; Shimura K
Nucleic Acids Symp Ser; 1984; (15):181-4. PubMed ID: 6097882
[TBL] [Abstract][Full Text] [Related]
19. Biochemical characterization of the structure-specific DNA-binding protein Cmb1 from Schizosaccharomyces pombe.
Sassoon J; Lilie H; Baumann U; Kohli J
J Mol Biol; 2001 Jun; 309(5):1101-15. PubMed ID: 11399082
[TBL] [Abstract][Full Text] [Related]
20. Formation of large nucleoprotein complexes upon binding of the high-mobility-group (HMG) box B-domain of HMG1 protein to supercoiled DNA.
Stros M; Reich J
Eur J Biochem; 1998 Jan; 251(1-2):427-34. PubMed ID: 9492314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
